Overview

Pemetrexed and Gemcitabine in Patients With Advanced Head and Neck Cancer

Status:
Terminated
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to look at how well the combination of two chemotherapy drugs, pemetrexed (Alimta) and gemcitabine (Gemzar) work to treat your cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Fox Chase Cancer Center
Collaborator:
Eli Lilly and Company
Treatments:
Gemcitabine
Pemetrexed